Minerva Neurosciences Names Remy Luthringer as Executive Chairman and William Doyle as Lead Independent Director
February 05, 2018 08:30 ET
|
Minerva Neurosciences, Inc
WALTHAM, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS)...